Objectives: To evaluate the acute recoil of the ABSORB bioabsorbable vascular scaffold (BVS) and its relationship with procedural characteristics in a real world population.
Background: In vivo acute recoil of the BVS was evaluated in selected patients.
Methods: Acute recoil was studied with videodensitometry in a consecutive series of patients treated by means of a BVS, and the results were compared with those obtained in subjects receiving an everolimus-eluting stent (EES). Recoil was defined as the difference between the mean diameter of the fully expanded balloon on which the device was mounted (or the mean diameter of the post-dilatation balloon), and the mean luminal diameter of the treated segment immediately after the final inflation.
Results: Recoil was assessed in 106 lesions treated with a BVS and 71 treated with an EES. The absolute and percent recoil of the BVS were significantly greater (0.32 ± 0.16 mm and 10% ± 5% vs. 0.17 ± 0.07 and 5% ± 3%; P < 0.001). Multiple regression analysis showed that BVS use was associated with acute recoil (β = 0.477; P<0.001). Suboptimal lesion preparation (residual stenosis after balloon angioplasty >20%) (β = 0.217; P = 0.027) and a small vessel reference diameter (β = 0.335; P = 0.002) were associated with increased BVS but not EES recoil.
Conclusions: In unselected patients, the acute recoil of the BVS was significantly greater than that of the metal EES. In the BVS group, residual stenosis after predilatation correlated with percent recoil, and so optimal lesion preparation seems to be mandatory in order to maximize the mechanical properties of the scaffold.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ccd.26148 | DOI Listing |
Toxicol Sci
January 2025
Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, 08854.
Ozone is an urban air pollutant, known to cause lung injury and altered function. Using established models of acute (0.8 ppm, 3 h) and episodic (1.
View Article and Find Full Text PDFFuture Cardiol
January 2025
Division of Interventional Cardiology, La Paz University Hospital, IdiPAZ, CIBER-CV, Madrid, 28046, Spain.
Artif Organs
October 2024
Department of Bionanosystem Engineering, Graduate School, Jeonbuk National University, Jeonju, Republic of Korea.
Background: Poly-L-lactic acid (PLLA) is one of the representative polymeric materials serving as bioresorbable stents (BRS) for cardiovascular disease due to its proper biodegradation, high biocompatibility, and adequate mechanical properties among polymer candidates for BRS. However, PLLA BRS as cardiovascular stents also have limitations because their mechanical properties including low radial strength and high elastic recoil are inferior to those of metallic-based BRS stents.
Methods: In the study, we developed and manufactured distinct and novel types of stent geometries for investigating mechanical properties of thin-walled PLLA BRS (110 μm) for cardiovascular applications.
J Hand Surg Glob Online
September 2024
Division of Upper Extremity Surgery, Department of Orthopedic Surgery, Emory University, Atlanta, GA.
J Endovasc Ther
September 2024
Syntropic Core Lab, Columbus, OH, USA.
Purpose: Vessel recoil is a common phenomenon occurring in the tibial vessels following balloon angioplasty. This study examined the occurrence and short-term impact of acute vessel recoil in a subset of patients treated with retrievable scaffold therapy (RST) via the Spur Peripheral Retrievable Scaffold System (Spur).
Methods: Patients with tibial disease underwent angiography immediately following RST, and then 15 minutes post-treatment.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!